Making Football Safer for Women: Implementing an Injury Prevention Program
Launched by LA TROBE UNIVERSITY · Apr 20, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on making football safer for women by implementing an injury prevention program called Prep-to-Play. The study aims to find the best ways to support coaches in teaching this program to female community football teams in Victoria, Australia. The trial will involve at least 140 teams with players aged 13 and older, competing in various age groups. Coaches will receive training and support to help them use the program effectively, and researchers will monitor the impact on injuries over two football seasons.
To participate in this trial, coaches must agree to be trained in the Prep-to-Play program and lead a team that practices at least once a week. The team should include players aged 13 and older who are registered to play community football. It's important to note that players younger than 13 or those who cannot understand written English will not be eligible. Participants can expect to engage in a structured program aimed at reducing injuries, such as knee and head injuries, while enjoying the sport they love.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria
- • Coach consents to be trained and to implement Prep-to-Play
- • Team includes players aged 13 years and above registered to play community football
- • The team trains at least once per week in addition to match-play
- • Coach has at least Level I coach accreditation (or enrolled to be accredited in 2021)
- Exclusion Criteria:
- • Inability to understand written English
- • Players aged less than 13 years
About La Trobe University
La Trobe University is a leading educational institution based in Australia, renowned for its commitment to research excellence and innovation in health sciences. As a clinical trial sponsor, La Trobe University leverages its extensive academic resources and multidisciplinary expertise to advance medical research and improve patient outcomes. The university fosters collaboration between researchers, healthcare professionals, and industry partners, ensuring that clinical trials are conducted with the highest standards of integrity and scientific rigor. Through its dedication to ethical practices and community engagement, La Trobe University aims to contribute significantly to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Kay Crossley, PhD, PT
Principal Investigator
La Trobe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials